Medarex Partners With GenPat77 To Develop Human Therapeutic Antibodies
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement adds another player to Medarex’ roster of development partners, which include Bristol-Myers Squibb and J&J.